ActiveCare® is a trademark brand of MCS Medical Compression Systems.
ActiveCare® fully meets the American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (ACCP) 2012 Guidelines to prevent DVT after Total Joint Replacement for the whole duration of treatment from hospital to home.
ActiveCare® is an economically viable DVT prevention. No reported major bleeding, which may lead to costly readmission.
ActiveCare® is currently used in more than 80 surgical centers across the country daily. ActiveCare® line of products are cleared for market in several geographies.
Click here to learn more about our clinical studies.
MCS Medical Compression Systems is a medical device company that develops manufactures and markets the brand ActiveCare®, innovative non-invasive solutions for the prevention of Deep Vein Thrombosis (DVT). Founded in 1997, MCS is an Israeli public company, traded on the Tel Aviv Stock Exchange (TASE: MDCL). MCS Inc., the company’s subsidiary, is located in the USA.